Comparison of Risperidone vs Aripiprazole in amphetamine induced psychotic disorder

Efficacy of Risperidone vs Aripiprazole in amphetamine induced psychotic disorder

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT201205029620N1

Enrollment

Registered

2012-08-21

Start date

2012-09-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

amphtamine induced psychotic disorder. F 15 .150 - F 15 .151 - F 15 .159

Interventions

Intervention 1: Risperidone 4 mg daily. Intervention 2: aripiprazole 15mg/daily.

Treatment - Drugs

Risperidone 4 mg daily

aripiprazole 15mg/daily

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1- diagnosis of amphetamine induced psychotic Disorder; 2- Patients agreement for treatment. Exclusion criteria: 1- any history of previous medical & psychiatric disorders; 2- any medication which currently is used; 3- any substance which currently is used.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Severity of psychotic symptoms. Timepoint: 6 Weeks after begining of treatment course. Method of measurement: PANSS Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactVahid Farnia

Kermanshah university of medical sciences

vfarnia@kums.ac.ir+98 83 1826 0700

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026